{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:19:26Z","timestamp":1790907566722,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007230","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T00:00:00Z","timestamp":1323216000000}}],"reference-count":47,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007230.pub2","type":"journal-article","created":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T16:23:45Z","timestamp":1323102225000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Edaravone for acute ischaemic stroke"],"prefix":"10.1002","volume":"2011","author":[{"given":"Shejun","family":"Feng","sequence":"first","affiliation":[{"name":"(b) Second Department of Neurology, Central Hospital; (a) Department of Neurology, West China Hospital, Sichuan University, Chengdu, China; Handan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Yang","sequence":"additional","affiliation":[{"name":"Zhong Shan Hospital, Xiamen University; Department of Neurology; No 201 Hubinnanlu Xiamen Fujian China 361004"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizheng","family":"Li","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Yuan","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Chinese Cochrane Centre; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihong","family":"Zhang","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntao","family":"Li","sequence":"additional","affiliation":[{"name":"Central Hospital; Second Department of Neurology; No. 15 Zhonghua South Street Handan China 056001"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,12,7]]},"reference":[{"key":"10.1002\/14651858.CD007230.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000069318","article-title":"Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction","volume":"15","author":"Edaravone Acute Brain Infarction Study Group","year":"2003","journal-title":"Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD007230.pub2-BIB0002|cit2","first-page":"105","article-title":"Efficacy and safety evaluation of edaravone injection in treatment of acute cerebral infarction: a multicenter, double-blind, and randomized controlled clinical trial","volume":"26","author":"Zhang","year":"2007","journal-title":"Chinese Journal of New Drugs and Clinical Remedies"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0003|cit3","first-page":"966","article-title":"Randomized controlled trial of edaravone injection in the treatment of acute cerebral infarction","volume":"34","author":"Zhou","year":"2007","journal-title":"Modern Preventive Medicine"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0004|cit4","first-page":"546","article-title":"The influence on free radicals and correlation with serum ferritin after therapy with edaravone in acute cerebral infarction","volume":"8","author":"Du","year":"2006","journal-title":"Chinese Journal of Geriatric Heart Brain and Vessel Diseases"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0005|cit5","first-page":"268","article-title":"Clinical analysis of treatment on acute massive hemispheric infarction with edaravone, ozagrel and mannitol","volume":"25","author":"Guo","year":"2008","journal-title":"Chinese Journal of Modern Applied Pharmacy"},{"issue":"5","key":"10.1002\/14651858.CD007230.pub2-BIB0006|cit6","first-page":"313","article-title":"Edaravone for elderly patients with acute cerebral infarction","volume":"33","author":"He","year":"2007","journal-title":"Chinese Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0007|cit7","first-page":"233","article-title":"Edaravone for acute cerebral infarction","volume":"28","author":"Hu","year":"2008","journal-title":"Journal of Southern Medical University"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0008|cit8","first-page":"364","article-title":"Edaravone for elderly patients with acute cerebral infarction","volume":"28","author":"Long","year":"2008","journal-title":"Chinese Journal of Gerontology"},{"issue":"10","key":"10.1002\/14651858.CD007230.pub2-BIB0009|cit9","first-page":"4","article-title":"Clinical observation on edaravone for the patients with acute cerebral infarction","volume":"12","author":"Shan","year":"2009","journal-title":"Chinese Journal of Practical Nervous Diseases"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0010|cit10","first-page":"1342","article-title":"Efficacy and safety of edaravone for acute cerebral infarction","volume":"14","author":"Wang","year":"2005","journal-title":"Chinese Journal of New Drugs"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0011|cit11","first-page":"1342","article-title":"Efficacy and safety of edaravone for acute cerebral infarction","volume":"14","author":"Wang","year":"2005","journal-title":"Chinese New Drugs Journal"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0012|cit12","unstructured":"Song ZH Du YF Clinical evaluation of edaravone on acute cerebral infarction and effects on cats Shandong University Master's Thesis 2006"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0013|cit13","first-page":"154","article-title":"Clinical observation on the therapeutic effect of edaravone on cerebral infarction","volume":"24","author":"Wang","year":"2007","journal-title":"Chinese Journal of Hospital Pharmacy"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0014|cit14","first-page":"68","article-title":"Clinical study about combined treatment of ozagrel and edaravone for progressing stroke","volume":"48","author":"Xu","year":"2008","journal-title":"Shandong Medical Journal"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0015|cit15","first-page":"82","article-title":"Edaravone for acute cerebral infraction and influence on serum phosphatides acid","volume":"48","author":"Xu","year":"2008","journal-title":"Shandong Medical Journal"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0016|cit16","first-page":"99","article-title":"Edaravone for acute cerebral infarction","volume":"41","author":"Yang","year":"2006","journal-title":"Acta Universitis Medicinalis Anhui"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0017|cit17","first-page":"2440","article-title":"Edaravone of acute cerebral infarction","volume":"27","author":"Yu","year":"2007","journal-title":"Chinese Journal of Gerontology"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0018|cit18","first-page":"336","article-title":"Influence and significance of edaravone on serum C-reactive protein level in acute cerebral infarction patients","volume":"23","author":"Zhang","year":"2006","journal-title":"Chinese Journal of Hospital Pharmacy"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0019|cit19","first-page":"184","article-title":"Therapeutic effect of edaravone on the patients with acute cerebral infarction","volume":"11","author":"Di","year":"2004","journal-title":"Journal of Clinical Neurology"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0020|cit20","first-page":"113","article-title":"Efficacy evaluation of edaravone injection in treatment of acute cerebral infarction","volume":"25","author":"Gu","year":"2005","journal-title":"Chinese Journal of New Drugs and Clinical Remedies"},{"issue":"4","key":"10.1002\/14651858.CD007230.pub2-BIB0021|cit21","first-page":"e106","article-title":"Edaravone in combination with argatroban for the treatment of acute atherothrombotic brain infarction: the Edaravone Argatroban Stroke Therapy (EAST) study","volume":"40","author":"Minematsu","year":"2009","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD007230.pub2-BIB0022|cit22","first-page":"590","article-title":"The clinical research of moderate hypothermia and radical scavenger in the treatment of cerebral infarction","volume":"24","author":"Zhou","year":"2007","journal-title":"Journal of Apoplexy and Nervous Diseases"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0023|cit23","unstructured":"Goel D ECCT-HIS: Edaravone-Citicoline Comparative Trial in Head injury and Stroke http:\/\/www.strokecenter.org\/trials\/TrialDetail.aspx?tid=789"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0024|cit24","unstructured":"Mitsubishi Tanabe Pharma Corporation Safety and pharmacokinetics of MCI-186 in subjects with acute ischemic stroke http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00821821"},{"issue":"4","key":"10.1002\/14651858.CD007230.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/01.STR.19.4.480","article-title":"Attenuation of ischemic and post-ischemic brain edema in rats by a novel free radical scavenger","volume":"19","author":"Abe","year":"1988","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD007230.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/CIRCULATIONAHA.106.179918","article-title":"Heart disease and stroke statistics - 2007 Update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"115","author":"Rosamond","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD007230.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000069318","article-title":"Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction: randomized, placebo-controlled, double-blind study at multicenters","volume":"15","author":"Edaravone Acute Infarction Study Group","year":"2003","journal-title":"Cerebrovascular Diseases"},{"issue":"7109","key":"10.1002\/14651858.CD007230.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD007230.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1568007053544156","article-title":"Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers","volume":"4","author":"Green","year":"2005","journal-title":"Current Drug Targets. CNS and Neurological Disorders"},{"issue":"5","key":"10.1002\/14651858.CD007230.pub2-BIB0030|cit30","first-page":"541","article-title":"Experience from a multicentre stroke register: a preliminary report","volume":"54","author":"Hatano","year":"1976","journal-title":"Bulletin of the World Health Organization"},{"issue":"7414","key":"10.1002\/14651858.CD007230.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0032|cit32","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008] The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1517\/14656566.2010.493558","article-title":"A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?","volume":"11","author":"Lapchak","year":"2010","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"6","key":"10.1002\/14651858.CD007230.pub2-BIB0034|cit34","first-page":"411","article-title":"Meta-analysis of edaravone in treatment of acute cerebral infarction","volume":"18","author":"Li","year":"2009","journal-title":"Chinese Journal of Pharmacoepidemiology"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S1474-4422(07)70004-2","article-title":"Stroke in China: epidemiology, prevention, and management strategies","volume":"6","author":"Liu","year":"2007","journal-title":"Lancet Neurology"},{"issue":"9","key":"10.1002\/14651858.CD007230.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/01.STR.20.9.1236","article-title":"Effect of MCI-186 on brain edema in rats","volume":"20","author":"Nishi","year":"1989","journal-title":"Stroke"},{"issue":"11","key":"10.1002\/14651858.CD007230.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.STR.20.11.1557","article-title":"Effect of MCI-186 on ischemia-induced changes in monoamine metabolism in rat brain","volume":"20","author":"Oishi","year":"1989","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0038|cit38","first-page":"2864","article-title":"Meta-analysis on the effect of treatment of acute cerebral infarction with edaravone","volume":"16","author":"Qin","year":"2010","journal-title":"Medical Recapitulate"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0039|cit39","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"3","key":"10.1002\/14651858.CD007230.pub2-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000029.pub2","article-title":"Antiplatelet therapy for acute ischaemic stroke","author":"Sandercock","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD007230.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1161\/01.STR.30.8.1538","article-title":"Use of the Barthel index and modified Rankin scale in acute stroke trials","volume":"30","author":"Sulter","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0197-2456(97)00150-5","article-title":"Do certain countries produce only positive results? A systematic review of controlled trials","volume":"19","author":"Vickers","year":"1998","journal-title":"Controlled Clinical Trials"},{"issue":"3","key":"10.1002\/14651858.CD007230.pub2-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000213","article-title":"Thrombolysis for acute ischaemic stroke","author":"Wardlaw","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD007230.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0022-3565(25)38652-0","article-title":"Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions","volume":"268","author":"Watanabe","year":"1994","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/13510002.1996.11747069","article-title":"Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin- 5-one","volume":"2","author":"Yamamoto","year":"1996","journal-title":"Redox Report"},{"issue":"1-2","key":"10.1002\/14651858.CD007230.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0006-8993(97)00490-3","article-title":"Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia","volume":"762","author":"Yamamoto","year":"1997","journal-title":"Brain Research"},{"key":"10.1002\/14651858.CD007230.pub2-BIB0047|cit47","first-page":"18","article-title":"Edaravone for acute cerebral infarction: a systematic review","volume":"1","author":"Yang","year":"2006","journal-title":"Chinese Evidence-Based Medicine"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007230.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T19:47:26Z","timestamp":1764618446000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007230.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Stroke Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,7]]},"references-count":47,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007230.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,7]]}}}